D-0384-2026 Class II Ongoing
FDA drug recall D-0384-2026 was initiated by Rising Pharma Holding, Inc. on Mar 3, 2026 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing The recall status is ongoing. Affected quantity: 1200 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 11, 2026
- Initiation Date
- Mar 3, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1200 bottles
Product description
Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan, NDC 16571-816-51.
Reason for recall
Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing
Distribution pattern
Nationwide within the U.S
Code information
Lot #: 1TM0524003A, Exp. Date 09/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0384-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026